November 2009
Lab21 acquires personalised medicine diagnostic services business

July 2009
Appointment of Alun Williams as Chief Executive to establish Delphic as a leading supplier of companion diagnostics to the healthcare and pharmaceutical sectors

January 2009
Acquisition of iQur’s diagnostics business including pre-diagnostic screening service for HIV and hepatitis

September 2008
Launch of hepatitis diagnostics one-stop-shop including therapeutic drug monitoring

August 2008
Award of CAP certification (Liverpool laboratory)

November 2007
Initiation of sample reception service in Argentina

May 2007
Award of GCLP certification (Liverpool laboratory)

March 2007
Initiation of sample reception services in Italy and Spain

June 2006
Opening of ‘state-of-the-art’ pharmacology laboratory in Merseybio complex in Liverpool

October 2005
Funding round: MMC Ventures, The Capital Fund, Ulive (University of Liverpool) and management team

October 2005
Spin-out of world-leading therapeutic drug monitoring service from The University of Liverpool

July 2005
Launch of first commercially available genetic service for an HIV drug; HLA-B*5701 to screen for hypersensitivity to abacavir

May 2005
Acquisition of Genovar Bioscience, an ISO 9001:2000 certified genetics laboratory